In conclusion, we have modified a dendritic cell-bases protocol to be efficient for T-cell clonal expansion, obtained a potent TCR via single-cell sequencing, and successfully tested it in an in vitro cytotoxicity test against a MAGE-A3-positive tumor. This evidence concerns the gene MAGEA3 and neoplasm.